Reporting atypical imaging features such as asymmetrical macular thinning is important because it expands the recognized spectrum of PPRCA and assists in differentiating it from post-inflammatory retinopathies and CRB1-related dystrophies. The gene discussed is CRB1; the disease is pigmented paravenous retinochoroidal atrophy.